Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96370422 | 9637042 | 2 | F | 20160801 | 20131022 | 20160812 | EXP | US-RANBAXY-2013US-74227 | RANBAXY | IUPPA CA, DIEFENDERFER LA. RISPERIDONE-INDUCED PISA SYNDROME IN MS: RESOLUTION WITH LURASIDONE AND RECURRENCE WITH CHLORPROMAZINE. ANN PHARMACOTHER. 2013;JAN;47(9):1223-1228 | 31.00 | YR | M | Y | 75.90000 | KG | 20160812 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96370422 | 9637042 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 6 MG, DAILY | Y | 77542 | 6 | MG | |||||||
| 96370422 | 9637042 | 2 | I | Clomipramine | CLOMIPRAMINE | 1 | Unknown | 25 MG, QD | 0 | 25 | MG | ||||||||
| 96370422 | 9637042 | 3 | I | Clomipramine | CLOMIPRAMINE | 1 | TITRATED FROM 25 MG DAILY TO 100 MG DAILY | 0 | |||||||||||
| 96370422 | 9637042 | 4 | I | Clomipramine | CLOMIPRAMINE | 1 | Unknown | 200 MG, QD | 0 | 200 | MG | ||||||||
| 96370422 | 9637042 | 5 | I | Clomipramine | CLOMIPRAMINE | 1 | Unknown | 100 MG, DAILY | 0 | 100 | MG | ||||||||
| 96370422 | 9637042 | 6 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 50 MG, DAILY | Y | 0 | 50 | MG | |||||||
| 96370422 | 9637042 | 7 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 25 MG, DAILY | U | 0 | 25 | MG | |||||||
| 96370422 | 9637042 | 8 | C | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Unknown | 1250 MG, DAILY | U | 0 | 1250 | MG | |||||||
| 96370422 | 9637042 | 9 | C | Docusate | DOCUSATE | 1 | Unknown | 100 MG, DAILY | U | 0 | 100 | MG | |||||||
| 96370422 | 9637042 | 10 | C | Glatiramer | GLATIRAMER | 1 | Unknown | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
| 96370422 | 9637042 | 11 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, DAILY | 0 | 25 | MG | ||||||||
| 96370422 | 9637042 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 50 MG, DAILY | 0 | 50 | MG | |||||||||
| 96370422 | 9637042 | 13 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 50 MG, DAILY | U | 0 | 50 | MG | |||||||
| 96370422 | 9637042 | 14 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Unknown | 12.5 MG, TID | U | 0 | 12.5 | MG | Q8H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96370422 | 9637042 | 1 | Autism spectrum disorder |
| 96370422 | 9637042 | 2 | Obsessive-compulsive disorder |
| 96370422 | 9637042 | 5 | Obsessive-compulsive disorder |
| 96370422 | 9637042 | 6 | Product used for unknown indication |
| 96370422 | 9637042 | 7 | Product used for unknown indication |
| 96370422 | 9637042 | 8 | Product used for unknown indication |
| 96370422 | 9637042 | 9 | Product used for unknown indication |
| 96370422 | 9637042 | 10 | Product used for unknown indication |
| 96370422 | 9637042 | 11 | Product used for unknown indication |
| 96370422 | 9637042 | 13 | Product used for unknown indication |
| 96370422 | 9637042 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96370422 | 9637042 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96370422 | 9637042 | Drug interaction | |
| 96370422 | 9637042 | Pleurothotonus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |